| 1 |
Ogurtsova K, Guariguata L, Barengo NC, et al. IDF diabetes Atlas: Global estimates of undiagnosed diabetes in adults for 2021[J]. Diabetes Res Clin Pract, 2022, 183:109118.
|
| 2 |
Velarde K, Arvonen A, Gonzalez T, et al. A biologic and physical characterization of an injectable amniotic membrane designed for treating diabetic foot ulcers[J]. Bioengineering (Basel), 2024, 11(11):1087.
|
| 3 |
Wan X, Ni X, Xie Y, et al. Research progress and application prospect of adipose-derived stem cell secretome in diabetes foot ulcers healing[J]. Stem Cell Res Ther, 2024, 15(1):279.
|
| 4 |
Zhang Y, Li J, Lü L, et al. Evaluation of the efficacy of FDG-PET/CT in assessing the effects of BMMSC treatment in aged rhesus monkeys[J]. Stem Cell Res Ther, 2025, 16(1):448.
|
| 5 |
朱淑芳,牟丽莎. 间充质干细胞在1型糖尿病胰岛移植中的应用进展 [J]. 器官移植, 2024, 15 (2): 214-219.
|
| 6 |
Armstrong DG, Tan TW, Boulton AJM, et al. Diabetic foot ulcers: A review[J]. JAMA, 2023, 330(1):62-75.
|
| 7 |
Lopes L, Setia O, Aurshina A, et al. Stem cell therapy for diabetic foot ulcers: a review of preclinical and clinical research[J]. Stem Cell Res Ther, 2018, 9:188.
|
| 8 |
Chen L, Sun S, Gao Y, et al. Global mortality of diabetic foot ulcer: A systematic review and meta-analysis of observational studies[J]. Diabetes Obes Metab, 2023, 25(1):36-45.
|
| 9 |
Hurst JE, Barn R, Gibson L, et al. Geospatial mapping and data linkage uncovers variability in outcomes of foot disease according to multiple deprivation:a population cohort study of people with diabetes[J]. Diabetologia, 2020, 63(3):659-667.
|
| 10 |
Huerta CT, Voza FA, Ortiz YY, et al. Mesenchymal stem cell-based therapy for non-healing wounds due to chronic limb-threatening ischemia: a review of preclinical and clinical studies[J]. Front Cardiovasc Med, 2023, 10:1113982.
|
| 11 |
Zhang C, Huang L, Wang X, et al. Topical and intravenous administration of human umbilical cord mesenchymal stem cells in patients with diabetic foot ulcer and peripheral arterial disease: a phase I pilot study with a 3-year follow-up[J]. Stem Cell Res Ther, 2022, 13(1):451.
|
| 12 |
Arango-Rodríguez ML, Mateus LC, Sossa CL, et al. A novel therapeutic management for diabetes patients with chronic limb-threatening ischemia: comparison of autologous bone marrow mononuclear cells versus allogenic Wharton jelly-derived mesenchymal stem cells[J]. Stem Cell Res Ther, 2023, 14(1):221.
|
| 13 |
Wang Y, Yi H, Song Y. The safety of MSC therapy over the past 15 years: a meta-analysis[J]. Stem Cell Res Ther, 2021, 12(1):545.
|
| 14 |
Thompson M, Mei SHJ, Wolfe D, et al. Cell therapy with intravascular administration of mesenchymal stromal cells continues to appear safe: an updated systematic review and meta-analysis[J]. EClinicalMedicine, 2020, 19:100249.
|
| 15 |
Wu D, Liu R, Cen X, et al. Preclinical study of engineering MSCs promoting diabetic wound healing and other inflammatory diseases through M2 polarization[J]. Stem Cell Res Ther, 2025, 16(1):113.
|
| 16 |
Pollak R, Anderson J, Altmanshofer B, et al. Human placenta-derived cells (PDA-002) in diabetic foot ulcer patients with and without peripheral artery disease: a phase 2 multi-center, randomised, double-blind, placebo-controlled trial[J]. Int Wound J, 2025, 22(10):e70769.
|
| 17 |
Chiang KJ, Chiu LC, Kang YN, et al. Autologous stem cell therapy for chronic lower extremity wounds: a meta-analysis of randomized controlled trials[J]. Cells, 2021, 10(12):3307.
|
| 18 |
Sun Y, Zhao J, Zhang L, et al. Effectiveness and safety of stem cell therapy for diabetic foot: a meta-analysis update[J]. Stem Cell Res Ther, 2022, 13(1):416.
|
| 19 |
Gupta PK, Shivashankar P, Rajkumar M, et al. Label extension, single-arm, phase Ⅲ study shows efficacy and safety of stempeucel® in patients with critical limb ischemia due to atherosclerotic peripheral arterial disease[J]. Stem Cell Res Ther, 2023, 14:60.
|
| 20 |
Low Wang CC, Chong T, Moore G, et al. Results of the phase 1 open- label safety study of umbilical cord lining mesenchymal stromal/stem cells (Corlicyte®) to heal chronic diabetic foot ulcers[J]. Biomedicines, 2024, 12(6):1375.
|
| 21 |
Moon KC, Suh HS, Kim KB, et al. Potential of allogeneic adipose-derived stem cell-hydrogel complex for treating diabetic foot ulcers[J]. Diabetes, 2019, 68(4):837-846.
|
| 22 |
Dash NR, Dash SN, Routray P, et al. Targeting nonhealing ulcers of lower extremity in human through autologous bone marrow-derived mesenchymal stem cells[J]. Rejuvenation Res, 2009, 12(5):359-366.
|
| 23 |
Kishta MS, Hafez AM, Hydara T, et al. The transforming role of wharton's jelly mesenchymal stem cell-derived exosomes for diabetic foot ulcer healing: a randomized controlled clinical trial[J]. Stem Cell Res Ther, 2025, 16:559.
|
| 24 |
Jafar H, Almousa R, Alhawari H, et al. Human umbilical cord mesenchymal stromal cells derivatives in treating diabetic foot ulcers: a phase Ⅰ/Ⅱ safety and efficacy trial[J]. Stem Cell Res Ther, 2025, 16(1):657.
|
| 25 |
Zhang H, Gu Y, Zhang K, et al. Safety and efficacy of umbilical cord mesenchymal stem cell therapy for diabetic foot ulcers and peripheral artery disease: a systematic review and meta-analysis of randomized controlled trials[J]. Int J Low Extrem Wounds, 2026, 6:15347346261426552.
|
| 26 |
Lin X, Lin Q. Heat shock-pretreated bone marrow mesenchymal stem cells accelerate wound healing in a diabetic foot ulcer rat model[J]. Diabet Med, 2025, 42(5):e15507.
|
| 27 |
Li W, Chen J, Yu L, et al. Mesenchymal stem cell-derived small extracellular vesicles-loaded GelMA microspheres enhance diabetic wound healing by promoting M2 macrophage polarization through p38 MAPK inhibition[J]. Mater Today Bio, 2025, 35:102423.
|
| 28 |
Wang Y, Jing L, Lei X, et al. Umbilical cord mesenchymal stem cell-derived apoptotic extracellular vesicles ameliorate cutaneous wound healing in type 2 diabetic mice via macrophage pyroptosis inhibition[J]. Stem Cell Res Ther, 2023, 14:257.
|
| 29 |
Su W, Yin Y, Zhao J, et al. Exosomes derived from umbilical cord-derived mesenchymal stem cells exposed to diabetic microenvironment enhance M2 macrophage polarization and protect against diabetic nephropathy[J]. FASEB J, 2024, 38(14):e23798.
|
| 30 |
Li J, Lin X, Wang J, et al. Dendritic cell repression by TNF-α-Primed exosomes accelerate t2dm wound healing through miR-146a-5p/TXNIP/NLRP3 axis[J]. Int J Nanomedicine, 2025, 20:9963-9980.
|
| 31 |
XB, YL, PW, et al. Adipose mesenchymal stem cell-derived exosomes rescue mitochondrial function through SIRT1 to improve diabetic wound healing[J]. Burns Trauma, 2025, 13:tkaf017.
|
| 32 |
Luo Y, Guo Q, Liu C, et al. Adipose mesenchymal stem cell-derived extracellular vesicles regulate PINK1/parkin-mediated mitophagy to repair high glucose-induced dermal fibroblast senescence and promote wound healing in rats with diabetic foot ulcer[J]. Acta Diabetol, 2025, 62(7):1041-1056.
|
| 33 |
Wang Z, Feng C, Liu H, et al. Hypoxia-induced adipose derived stem cells-derived exosomes promote diabetic wound healing through circ-0001747/miR-199a-5p/HIF-1α axis[J]. Arch Dermatol Res, 2025, 317(1):456.
|
| 34 |
Wu S, Zhou Z, Li Y, et al. Advancements in diabetic foot ulcer research: Focus on mesenchymal stem cells and their exosomes[J]. Heliyon, 2024, 10(17):e37031.
|
| 35 |
Wang J, Liang YJ, Pan X. Advances in the Role of Stem Cell-Derived Exosomes in Diabetic Foot Wound Healing[J]. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, 2025, 18:2767-2781.
|
| 36 |
Weng J, Chen Y, Zeng Y, et al. A novel hydrogel loaded with plant exosomes and stem cell exosomes as a new strategy for treating diabetic wounds[J]. Mater Today Bio, 2025, 32:101810.
|
| 37 |
Bi J, Wang H, Luo H, et al. Self-healing hydrogels loaded with selenium nanoparticles/chitosan/cellulose nanofibers as carriers of mesenchymal stem cells for diabetic wound healing[J]. Int J Biol Macromol, 2025, 322(Pt 4):146905.
|
| 38 |
Qiu ZY, Xu WC, Liang ZH. Bone marrow mesenchymal stem cell-derived exosomal miR-221-3p promotes angiogenesis and wound healing in diabetes via the downregulation of forkhead box P1[J]. Diabet Med, 2024, 41(9):e15386.
|
| 39 |
Wang Z, Xu H, Xue B, et al. MSC-derived exosomal circMYO9B accelerates diabetic wound healing by promoting angiogenesis through the hnRNPU/CBL/KDM1A/VEGFA axis[J]. Commun Biol, 2024, 7(1):1700.
|
| 40 |
Cheng B, Song X, Yin L, et al. HMOX1-overexpressing mesenchymal stem cell-derived exosomes facilitate diabetic wound healing by promoting angiogenesis and fibroblast function[J]. Biochem Biophys Res Commun, 2024, 690:149271.
|
| 41 |
Zhou J, Wei T, He Z. ADSCs enhance VEGFR3-mediated lymphangiogenesis via METTL3-mediated VEGF-C m6A modification to improve wound healing of diabetic foot ulcers[J]. Mol Med, 2021, 27(1):146.
|
| 42 |
Hu Y, Tao R, Chen L, et al. Exosomes derived from pioglitazone-pretreated MSCs accelerate diabetic wound healing through enhancing angiogenesis[J]. J Nanobiotechnology, 2021, 19(1):150.
|
| 43 |
Wang H, Bai Z, Qiu Y, et al. Empagliflozin-pretreated msc-derived exosomes enhance angiogenesis and wound healing via pten/akt/vegf pathway[J]. Int J Nanomedicine, 2025, 20:5119-5136.
|
| 44 |
Zhao X, Fu L, Zou H, et al. Optogenetic engineered umbilical cord MSC-derived exosomes for remodeling of the immune microenvironment in diabetic wounds and the promotion of tissue repair[J]. J Nanobiotechnology, 2023, 21(1):176.
|
| 45 |
Peng C, Xu H, Zhuang Q, et al. Placenta-derived mesenchymal stem cells promote diabetic wound healing via exosomal protein interaction networks[J]. Wound Repair Regen, 2024, 32(5):638-651.
|
| 46 |
Cao J, Liu Z, An W, et al. Fgfr2 is a crucial factor for adipose-derived mesenchymal stem cells in promoting diabetic foot ulcer healing through angiogenesis[J]. J Cell Mol Med, 2025, 29(21):e70942.
|
| 47 |
Dai W, Zhou H, Du J, et al. Mechanical stretching enhances the cellular and paracrine effects of bone marrow mesenchymal stem cells on diabetic wound healing[J]. Burns Trauma, 2025, 13:tkaf022.
|
| 48 |
Dama G, Du J, Zhu X, et al. Bone marrow-derived mesenchymal stem cells: A promising therapeutic option for the treatment of diabetic foot ulcers[J]. Diabetes Res Clin Pract, 2023, 195:110201.
|
| 49 |
Wang H, Chen L, Liu Y, et al. Implantation of placenta-derived mesenchymal stem cells accelerates murine dermal wound closure through immunomodulation[J]. Am J Transl Res, 2016, 8(11):4912-4921.
|
| 50 |
Zhang H, Gu Y, Zhang K, et al. Roles and mechanisms of umbilical cord mesenchymal stem cells in the treatment of diabetic foot: a review of preclinical and clinical studies[J]. J Diabetes Complications, 2024, 38(1):108671.
|
| 51 |
Nagarajan P, Prithiviraj R, Patil S J, et al. Adipose-derived stem cells for treatment of diabetic foot ulcers: a review[J]. Curr Stem Cell Res Ther, 2025, 20(5):509-523.
|
| 52 |
Nammian P, Asadi-Yousefabad SL, Daneshi S, et al. Comparative analysis of mouse bone marrow and adipose tissue mesenchymal stem cells for critical limb ischemia cell therapy[J]. Stem Cell Res Ther, 2021, 12(1):58.
|
| 53 |
Mcintosh K, Zvonic S, Garrett S, et al. The immunogenicity of human adipose-derived cells: temporal changes in vitro[J]. Stem Cells, 2006, 24(5):1246-1253.
|
| 54 |
Kokai LE, Marra K, Rubin JP. Adipose stem cells: biology and clinical applications for tissue repair and regeneration[J]. Transl Res, 2014, 163(4):399-408.
|
| 55 |
Hassanshahi A, Hassanshahi M, Khabbazi S, et al. Adipose-derived stem cells for wound healing[J]. J Cell Physiol, 2019, 234(6): 7903-7914.
|
| 56 |
Mihu CM, Mihu D, Costin N, et al. Isolation and characterization of stem cells from the placenta and the umbilical cord[J]. Rom J Morphol Embryol, 2008, 49(4):441-446.
|
| 57 |
Chang YJ, Shih DTBi, Tseng CP, et al. Disparate mesenchyme-lineage tendencies in mesenchymal stem cells from human bone marrow and umbilical cord blood[J]. Stem Cells, 2006, 24(3):679-685.
|
| 58 |
Shirbaghaee Z, Heidari Keshel S, Rasouli M, et al. Report of a phase 1 clinical trial for safety assessment of human placental mesenchymal stem cells therapy in patients with critical limb ischemia (CLI)[J]. Stem Cell Res Ther, 2023, 14(1):174.
|
| 59 |
Yan C, Xv Y, Lin Z, et al. Human umbilical cord mesenchymal stem cell-derived exosomes accelerate diabetic wound healing via ameliorating oxidative stress and promoting angiogenesis[J]. Front Bioeng Biotechnol, 2022, 10:829868.
|
| 60 |
El Hage R, Knippschild U, Arnold T, et al. Stem cell-based therapy: A promising treatment for diabetic foot ulcer[J]. Biomedicines, 2022, 10(7):1507.
|
| 61 |
Shi X, Zhang K, Yu F, et al. Advancements and innovative strategies in induced pluripotent stem cell-derived mesenchymal stem cell therapy: A comprehensive review[J]. Stem Cells International, 2024, 2024:4073485.
|
| 62 |
Tong L, Tang L, Tang B, et al. Impacts of stem cells from different sources on wound healing rate in diabetic foot ulcers: a systematic review and meta-analysis[J]. Front Genet, 2024, 15:1541992.
|
| 63 |
Huang J, Deng Q, Tsang LL, et al. Mesenchymal stem cells from perinatal tissues promote diabetic wound healing via PI3K/AKT activation[J]. Stem Cell Res Ther, 2025, 16(1):59.
|
| 64 |
Florea V, Rieger AC, Difede DL, et al. Dose comparison study of allogeneic mesenchymal stem cells in patients with ischemic cardiomyopathy (the trident study)[J]. Circ Res, 2017, 121(11):1279-1290.
|
| 65 |
Jin YZ, Lee JH. Mesenchymal Stem Cell Therapy for Bone Regeneration[J]. Clin Orthop Surg, 2018, 10(3):271-278.
|
| 66 |
Eltoukhy HS, Sinha G, Moore CA, et al. Secretome within the bone marrow microenvironment: A basis for mesenchymal stem cell treatment and role in cancer dormancy[J]. Biochimie, 2018, 155:92-103.
|
| 67 |
Luo R, Lu Y, Liu J, et al. Enhancement of the efficacy of mesenchymal stem cells in the treatment of ischemic diseases[J]. Biomed Pharmacother, 2019, 109:2022-2034.
|